cdmo.directory
← Compare landing

Asimov vs Charles River Laboratories

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAsimovCharles River Laboratories
SummaryAsimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Cell line development
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Expression: Mammalian
  • Expression: Cell-Free
  • Expression: Microbial
  • Expression: Viral Vector
  • Single-Use / Disposable
  • Stainless Steel
Locations
  • Headquarters, Boston, MA, USA
  • Headquarters, United States
  • North America, North America, USA/Canada
  • Europe, Europe, Multiple
  • Asia, Asia, Multiple
  • North America, North America
  • Europe, Europe
  • Asia, Asia
CertificationsData not yet provided.
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support

Find similar companies

Asimov alternatives · Charles River Laboratories alternatives

Markdown mirror: /compare/asimov/criver.md